SEC 13F Intelligence

A.r.t. Advisors, LLC / DNLI

A.r.t. Advisors, LLC’s Denali Therapeutics Inc Position

Does A.r.t. Advisors, LLC own Denali Therapeutics Inc (DNLI)? Not currently — the last reported position was 6.2K shares worth $517,000 in Q4 2020; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$517,000
Q4 2020
Shares
6.2K
% of Portfolio
+2.39%
Quarters Held
1
position exited

Position History DNLI

Reported value by quarter
Q4 ’20: $517,000Q4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20206.2K$517,000+2.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See A.r.t. Advisors, LLC’s full portfolio or all institutional holders of DNLI.